Nucleic Acid Therapeutics Initiative
  • Organisation
  • Science
  • Accelerator
    • Funding Platform
    • Funding Opportunities
    • Portfolio
  • Careers
  • News & Events

Portfolio Series: N Series

Systemic CAR mRNA Delivery to Splenic T Cells Exploits In Vivo CAR T Production Against Immunological Disorders

Posted on August 2, 2025 by Vernacular
Read More »

High Diversity Libraries for the Identification of Human Transferrin Receptor 1 Binders for Specific Delivery of Synthetic RNA to Skeletal Muscle Tissue In Vivo

Posted on August 2, 2025 by Vernacular
Read More »

Development of Novel LNPs through High-Throughput Screening

Posted on August 2, 2025 by Vernacular
Read More »

LNP Platform Technology for Targeted mRNA Delivery

Posted on August 2, 2025 by Vernacular
Read More »

Coacervates Microdroplets for in vivo Delivery of RNA

Posted on August 2, 2025 by Vernacular
Read More »

AIFFEL: Generative AI for Full-Length mRNA Therapeutic Design

Posted on August 1, 2025 by Vernacular
Read More »

Oligonucleotide Therapeutics with Built-in Elements for Cytoslic Delivery

Posted on August 1, 2025 by Vernacular
Read More »

A Discovery Platform to Harness Chemical Space of NAT

Posted on August 1, 2025 by Vernacular
Read More »

mRNA Foundry

Posted on August 1, 2025 by Vernacular
Read More »

Oligo Foundry

Posted on August 1, 2025 by Vernacular
Read More »
Email
LinkedIn
Nucleic Acid Therapeutics Initiative (NATi)
31 Biopolis Way, Nanos #05-01, Singapore 138669
© 2025 Nucleic Acid Therapeutics Initiative | Privacy Policy | Terms and Conditions
Nucleic Acid Therapeutics Initiative
Join OurMailing List